Events2Join

AbCellera Reports Q2 2024 Business Results


AbCellera Reports Q2 2024 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release ...

AbCellera Reports Q2 2024 Business Results - Yahoo Finance

AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported in US ...

Q2 2024 Earnings Results and Business Update

We use cookies on investors.abcellera.com to provide you with the best possible experience. If you wish to review the cookies we store, please select the Cookie ...

AbCellera Reports Q2 2024 Business Results | ABCL Stock News

Financial Analyst neutral. AbCellera's Q2 2024 results reveal a challenging financial quarter with revenue declining to $7.3 million from $10.1 ...

News Releases - AbCellera Biologics Inc. - Investor Relations

November 07, 2024. AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 ; November 04, 2024. AbCellera Reports Q3 2024 Business ...

Quarterly Results - AbCellera Biologics Inc. - Financials

Q2 Earnings. Webcast(opens in new window) · Presentation(opens in new window) ... Innovation. © 2024 AbCellera Biologics Inc. - All rights reserved. Team.

AbCellera to Report Second Quarter 2024 Financial Results on ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its second quarter. 2024 nancial results on Tuesday, ...

AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference ...

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue ...

AbCellera Biologics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $7.32 million for the quarter ...

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript

We expect research fee revenue to continue to trend lower as we increasingly focus on internal and co-development programs. Our research and ...

Q2'24 Earnings Call Summary

EARNINGS CALL SUMMARY. ABCL Business Results Q2 2024. NOTE: This document contains a condensed summary of AbCellera's 2024-08-06 earnings call.

AbCellera to Report Second Quarter 2024 Financial Results on ...

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 pm ...

AbCellera Biologics(ABCL.US) Q2 2024 Earnings Conference

Thefollowing is a summary of the AbCellera Biologics Inc. (ABCL) Q2 2024 Earnings Call Transcript:Financial Performance:AbCellera reported ...

abcl-20240630 - SEC.gov

0001703057 12-31 Q2 2024 false http://www.abcellera.com/20240630 ... While our financial results are reported in U.S. Dollars, the financial statements ...

ABCL SEC Filings - AbCellera Biologics Inc.- Annual Report, Proxy ...

NEWS RELEASE AbCellera Reports Q2 2023 Business Results 08/03/2023 ○Total revenue of $10 million, compared to $46 million in Q2 2022 ○Total cumulative partnered ...

AbCellera Biologics Inc. Common Shares - ABCL STOCK NEWS

AbCellera (ABCL) reported Q3 2024 financial results with total revenue of $6.5 million, slightly down from $6.6 million in Q3 2023. The company reported a net ...

AbCellera Reports Q3 2024 Business Results - The Globe and Mail

Revenue – Total revenue was $6.5 million, compared to $6.6 million in Q3 2023. In both periods, the majority of revenues were research fees ...

AbCellera to Report Third Quarter 2024 Financial Results ... - Cbonds

VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its third quarter 2024 financial results on ...

AbCellera Biologics : Reports Q3 2024 Business Results Form 8 K

downstreams in Q3 2024 (up from 84 on September 30, 2023). AbCellera's partners have advanced a cumulative total of 14 molecules into the clinic ...

Abcellera Biologics Inc. (ABCL) - 10-Q Quarterly Report ... - Last10K

VANCOUVER, British Columbia - AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. · “This quarter, we made ...